BHC | tickerfilter.com

Fundamental analysis

65%

Profitability 66%

Dept financing 50%

Liquidity 43%

Performance 73%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

5.22%

1 Month

-16.05%

3 Months

-29.35%

6 Months

-29.35%

1 Year

-29.35%

2 Year

-29.35%

Key data

Stock price

$5.44

P/E Ratio

0.00

DAY RANGE

$5.32 - $5.48

EPS

$0.24

52 WEEK RANGE

$4.25 - $7.88

52 WEEK CHANGE

-$29.35

MARKET CAP

2.964 B

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-30-2025

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$2,456,008

AVERAGE 30 VOLUME

$3,192,838

Company detail

CEO: Thomas J. Appio
Region: US
Website: bauschhealth.com
Employees: 19,900
IPO year: 2006

Issue type:
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment provides dermatological products in United States; and Solta medical aesthetic devices internationally.

BHC - Bausch Health Companies Inc.